摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(m-nitrobenzoyl)alanine | 117958-15-3

中文名称
——
中文别名
——
英文名称
(m-nitrobenzoyl)alanine
英文别名
(2S)-2-[(3-nitrobenzoyl)amino]propanoic acid
(m-nitrobenzoyl)alanine化学式
CAS
117958-15-3
化学式
C10H10N2O5
mdl
MFCD08485081
分子量
238.2
InChiKey
CDBXKLYOJGRINM-LURJTMIESA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1
  • 重原子数:
    17
  • 可旋转键数:
    3
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.2
  • 拓扑面积:
    112
  • 氢给体数:
    2
  • 氢受体数:
    5

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    乙醇(m-nitrobenzoyl)alanine盐酸 作用下, 生成 N-(3-nitro-benzoyl)-L-alanine ethyl ester
    参考文献:
    名称:
    High-resolution quantitative imaging of plagioclase composition using accumulated backscattered electron images: new constraints on oscillatory zoning
    摘要:
    Oscillatory zoning in plagioclase is investigated at small scale (less than or equal to10 mum) using accumulated backscattered electron (BSE) images as high-resolution imaging method. Combined with electron microprobe quantitative analysis. gray-value profiles across these images can be calibrated for An-content with a resolution of 0.5 mol% An. Applied to oscillatory-zoned crystals. this new application of BSE imaging allows better characterization of zoning patterns along a profile and quantification of wavelength. amplitude, and shape of the oscillations. We also obtain high-resolution information on the morphology of growth zones boundaries. This approach allows us to better classify the different types of "oscillations" and concentric zoning. Dissolution is more frequent than usually recognized. Major resorption surfaces crosscut several growth zones. Irregular 5-10-mum saw-tooth zones are delimited by faint wavy dissolution surfaces and must be distinguished from small-scale oscillations (less than or equal to1-3 pm) with straight boundaries. This suggests at least two mechanisms for the formation of these zoning patterns: faint oscillations are probably caused by local kinetic control whereas wavy dissolution surfaces involve magma chamber dynamics.
    DOI:
    10.1007/s004100100298
  • 作为产物:
    参考文献:
    名称:
    High-resolution quantitative imaging of plagioclase composition using accumulated backscattered electron images: new constraints on oscillatory zoning
    摘要:
    Oscillatory zoning in plagioclase is investigated at small scale (less than or equal to10 mum) using accumulated backscattered electron (BSE) images as high-resolution imaging method. Combined with electron microprobe quantitative analysis. gray-value profiles across these images can be calibrated for An-content with a resolution of 0.5 mol% An. Applied to oscillatory-zoned crystals. this new application of BSE imaging allows better characterization of zoning patterns along a profile and quantification of wavelength. amplitude, and shape of the oscillations. We also obtain high-resolution information on the morphology of growth zones boundaries. This approach allows us to better classify the different types of "oscillations" and concentric zoning. Dissolution is more frequent than usually recognized. Major resorption surfaces crosscut several growth zones. Irregular 5-10-mum saw-tooth zones are delimited by faint wavy dissolution surfaces and must be distinguished from small-scale oscillations (less than or equal to1-3 pm) with straight boundaries. This suggests at least two mechanisms for the formation of these zoning patterns: faint oscillations are probably caused by local kinetic control whereas wavy dissolution surfaces involve magma chamber dynamics.
    DOI:
    10.1007/s004100100298
点击查看最新优质反应信息

文献信息

  • [EN] KYNURENINE 3-MONOOXYGENASE (KMO) INHIBITORS, AND USES AND COMPOSITIONS THEREOF<br/>[FR] INHIBITEURS DE LA KYNURÉNINE 3-MONOOXYGÉNASE (KMO), ET UTILISATIONS ET COMPOSITIONS ASSOCIÉES
    申请人:UNIV LEICESTER
    公开号:WO2019102186A1
    公开(公告)日:2019-05-31
    There is provided compounds of formula (I) or pharmaceutically-acceptable salts thereof, wherein: L, X, R1, R2 and n have meanings provided in the description, which compounds are useful in the treatment of neurodegenerative and neuroinflammatory diseases.
    提供了具有以下结构式(I)或其药用盐的化合物,其中:L、X、R1、R2和n的含义如描述中所提供的,这些化合物在治疗神经退行性和神经炎症性疾病方面是有用的。
  • N-(4-Aryl-thiazol-2-yl)-sulfonamide und deren Verwendung
    申请人:F. HOFFMANN-LA ROCHE AG
    公开号:EP0819681A2
    公开(公告)日:1998-01-21
    Die Erfindung betrifft die Verwendung von Sulfonamid-Derivaten der allgemeinen Formel    worin Rnieder-Alkyl, Phenyl, Benzyl, Naphthyl, Pyridyl oder Thienyl, gegebenenfalls einfach oder mehrfach substituiert durch nieder-Alkyl, nieder-Alkoxy, nieder-Alkyl-carbonyl-amino, Halogen, Cycloalkyl, Nitro, Amino, Methylendioxy, Phenoxy oder Benzyloxy, wobei die aromatischen Ringe wiederum durch Nitro, Halogen oder Amino substituiert sein können, R1-R4Wasserstoff, Halogen, Hydroxy, nieder-Alkyl, Nitro, Cyano, Amino, nieder-Alkoxy, Benzyloxy, Trifluormethyl oder Phenyl, gegebenenfalls einfach oder mehrfach substituiert durch nieder-Alkyl, Trifluormethyl, Nitro, Amino oder Hydroxy, und wobei R1 und R2 oder R2 und R3 zusammen einen Benzolring bilden können, der gegebenenfalls substituiert sein kann durch Halogen, Trifluormethyl, Nitro, nieder-Alkyl oder nieder-Alkoxy, bedeuten, sowie von deren pharmazeutisch annehmbare Salze als Kynurenin-3-Hydroxylase Hemmstoffe bei der Bekämpfung oder Verhütung von neurodegenerativen Erkrankungen, neurologischen Erkrankungen als Folge einer Aktivierung des Immunsystems, von psychiatrischen Leiden bzw. zur Herstellung entsprechender Arzneimittel.
    本发明涉及通式如下的磺酰胺衍生物的用途 其中 Ris 低级烷基、苯基、苄基、萘基、吡啶基或噻吩基,可任选被低级烷基、低级烷氧基、低级烷基-羰基-氨基、卤素、环烷基、硝基、氨基、亚甲基二氧基、苯氧基或苄氧基单取代或多取代,其中芳环可依次被硝基、卤素或氨基取代、 R1-R4为氢、卤素、羟基、低级烷基、硝基、氰基、氨基、低级烷氧基、苄氧基、三氟甲基或苯基,可选择被低级烷基、三氟甲基、硝基、氨基或羟基单取代或多取代、 其中 R1 和 R2 或 R2 和 R3 可共同形成一个苯环,该苯环可任选被卤素、三氟甲基、硝基、低级烷基或低级烷氧基取代,其药学上可接受的盐类可作为犬尿氨酸-3-羟化酶抑制剂,用于控制或预防神经退行性疾病、免疫系统激活导致的神经系统疾病、精神疾病或制备相应的药物。
  • Treatment of aneurysms
    申请人:Georgia State University Research Foundation, Inc.
    公开号:US11376248B2
    公开(公告)日:2022-07-05
    The present invention provides methods for detecting and/or treating a subject having an aneurysm or at risk for developing an aneurysm. It has been discovered that a key metabolite of the kynurenine (Kyn) pathway, a major route for the metabolism of essential amino acid tryptophan (Trp) into nicotinamide adenine dinucleotide (NAD+), plays a critical role in the formation of aneurysms, for example abdominal aortic aneurysms. In particular, it has been discovered that 3-Hydroxyanthranilic acid (3-HAA), a product of kynureninase (KYNU), plays a causative role in the formation of aneurysms by, for example exerting pro-inflammatory effects on vascular smooth muscle cells. It has further been discovered that elevated levels of 3-HAA are indicative of the presence and/or progression of an aneurysm, and 3-HAA levels correlate with the size (aortic diameter) of the aneurysm.
    本发明提供了检测和/或治疗患有动脉瘤或有罹患动脉瘤风险的受试者的方法。现已发现,犬尿氨酸(Kyn)途径的一种关键代谢物--将必需氨基酸色氨酸(Trp)代谢为烟酰胺腺嘌呤二核苷酸(NAD+)的主要途径--在动脉瘤(例如腹主动脉瘤)的形成中起着关键作用。特别是,研究发现,3-羟基氨基苯甲酸(3-HAA)是犬尿苷酶(KYNU)的产物,通过对血管平滑肌细胞产生促炎作用等方式,在动脉瘤的形成过程中起着致病作用。研究进一步发现,3-HAA 水平的升高表明动脉瘤的存在和/或发展,3-HAA 水平与动脉瘤的大小(主动脉直径)相关。
  • KYNURENINE 3-MONOOXYGENASE (KMO) INHIBITORS, AND USES AND COMPOSITIONS THEREOF
    申请人:University of Leicester
    公开号:EP3713935A1
    公开(公告)日:2020-09-30
  • Methods and Compositions for the Treatment of Alcoholism and Alcohol Dependence
    申请人:Badawy Abdulla Abu-Bakr
    公开号:US20080076796A1
    公开(公告)日:2008-03-27
    Use is disclosed of (a) an AlDH-inhibitory amount of a Trp metabolite, or an analogue or derivative thereof or (b) a bioprecursor thereof, or (c) a potentiator of (a) and/or (b), in the preparation of a medicament for treating alcoholism and/or alcohol dependence.
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐